[Coronary involvement in systemic lupus erythematosus]. 1997

G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
Clinique dermatologique, Hôpital Charles Nicolle, Rouen.

BACKGROUND Coronary artery disease is an uncommon event in lupus erythematosus. The mechanisms responsible for coronary occlusion are probably complex and intermixed. We report three patients with lupus erythematosus and antiphospholipid antibodies who had coronary artery disease diagnosed with coronary angiogram. METHODS Coronary artery disease occurred in three young patients aged from 21 to 35 years 3 to 11 years after the onset of lupus. They all had antiphospholipid antibodies. They had been treated with corticosteroids for 6 to 36 months. Two of them were smokers. Angiograms showed coronary occlusion two patients while the third one had probable myocardial microvasculopathy. The lupus was quiescent in all cases when coronary artery disease occurred. CONCLUSIONS Antiphospholipid antibodies associated with smoking may be involved in the pathogenesis of coronary artery disease in these 3 patients.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D017023 Coronary Angiography Radiography of the vascular system of the heart muscle after injection of a contrast medium. Angiography, Coronary,Angiographies, Coronary,Coronary Angiographies
D017152 Antibodies, Antiphospholipid Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with certain autoimmune diseases (e.g., SYSTEMIC LUPUS ERYTHEMATOSUS and ANTIPHOSPHOLIPID SYNDROME), some non-autoimmune diseases, and also in healthy individuals. Antiphospholipid Antibodies,Antiphospholipid Autoantibodies,Antiphospholipid Autoantibody,Phospholipid Autoantibodies,Phospholipid Autoantibody,Antiphospholipid Antibody,Antibody, Antiphospholipid,Autoantibody, Antiphospholipid,Autoantibody, Phospholipid

Related Publications

G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
November 2015, Current opinion in ophthalmology,
G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
July 1992, Israel journal of medical sciences,
G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
March 1997, Harefuah,
G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
November 1987, Revista clinica espanola,
G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
January 2005, Lupus,
G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
January 1988, American journal of physiologic imaging,
G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
November 1987, Seminars in arthritis and rheumatism,
G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
October 1990, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
February 1971, Singapore medical journal,
G Lair, and P Joly, and G Desrumeaux, and E Thomine, and M Godin, and F Tron, and B Letac, and P Lauret
December 2008, Revue des maladies respiratoires,
Copied contents to your clipboard!